|
US38170A
(en)
|
|
1863-04-14 |
|
Improvement in lamps |
|
US5294533A
(en)
|
1988-07-05 |
1994-03-15 |
Baylor College Of Medicine |
Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
|
|
US5135917A
(en)
|
1990-07-12 |
1992-08-04 |
Nova Pharmaceutical Corporation |
Interleukin receptor expression inhibiting antisense oligonucleotides
|
|
US5271941A
(en)
|
1990-11-02 |
1993-12-21 |
Cho Chung Yoon S |
Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
|
|
US5786138A
(en)
|
1993-01-29 |
1998-07-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Hyperstabilizing antisense nucleic acid binding agents
|
|
DE69425890D1
(de)
|
1993-06-04 |
2000-10-19 |
Us Health |
Verfahren zur behandlung von kaposi-sarcoma mit antisense-oligonukleotide
|
|
US5578716A
(en)
|
1993-12-01 |
1996-11-26 |
Mcgill University |
DNA methyltransferase antisense oligonucleotides
|
|
US5641754A
(en)
|
1994-01-10 |
1997-06-24 |
The Board Of Regents Of The University Of Nebraska |
Antisense oligonucleotide compositions for selectively killing cancer cells
|
|
US5624813A
(en)
|
1994-04-21 |
1997-04-29 |
Mahant; Vijay K. |
NAD(P)+ /NAD(P)H based chemiluminescent diagnostics
|
|
AU3222795A
(en)
|
1994-08-09 |
1996-03-07 |
Ciba-Geigy Ag |
Antitumor antisense oligonucleotides
|
|
US5856103A
(en)
|
1994-10-07 |
1999-01-05 |
Board Of Regents The University Of Texas |
Method for selectively ranking sequences for antisense targeting
|
|
US5994320A
(en)
|
1995-02-06 |
1999-11-30 |
Regents Of The University Of Minnesota |
Antisense oligonucleotides and methods for treating central nervous system tumors
|
|
IT1275862B1
(it)
|
1995-03-03 |
1997-10-24 |
Consiglio Nazionale Ricerche |
Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento
|
|
US6040296A
(en)
|
1995-06-07 |
2000-03-21 |
East Carolina University |
Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
FR2739029B1
(fr)
|
1995-09-21 |
1997-11-21 |
Roussel Uclaf |
Nouvelle application therapeutique des composes antimineralo-corticoides
|
|
AU7286696A
(en)
|
1995-10-13 |
1997-05-07 |
F. Hoffmann-La Roche Ag |
Antisense oligomers
|
|
CN1202900A
(zh)
|
1995-11-21 |
1998-12-23 |
Icn药品公司 |
用il－8和il－8受体的反义寡核苷酸抑制肿瘤生长
|
|
WO1997020942A1
(en)
|
1995-12-05 |
1997-06-12 |
Piao Yun Shang |
Hsd17b1 promoter, enhancer, silencer and use thereof
|
|
JP2000506384A
(ja)
|
1996-02-15 |
2000-05-30 |
ナショナル インスティチューツ オブ ヘルス |
ＲＮａｓｅ Ｌ アクチベーター及びＲＳＶ感染の治療に有効なアンチセンスオリゴヌクレオチド
|
|
US5955590A
(en)
|
1996-07-15 |
1999-09-21 |
Worcester Foundation For Biomedical Research |
Conjugates of minor groove DNA binders with antisense oligonucleotides
|
|
US6046004A
(en)
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
|
JPH1142091A
(ja)
|
1997-07-25 |
1999-02-16 |
Toagosei Co Ltd |
アンチセンス核酸化合物
|
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US6046319A
(en)
|
1997-10-22 |
2000-04-04 |
University Technologies International, Inc. |
Antisense oligodeoxynucleotides regulating expression of TNF-α
|
|
JP3868740B2
(ja)
|
1998-03-10 |
2007-01-17 |
ジェネンテック・インコーポレーテッド |
新規なポリペプチド及びそれをコードする核酸
|
|
RU2000125533A
(ru)
|
1998-03-11 |
2002-10-20 |
Эндорешерш, Инк. (Ca) |
Ингибиторы 17-бета-гидроксистероиддегидрогеназ 5 и 3 типа и способы их применения
|
|
US6007995A
(en)
|
1998-06-26 |
1999-12-28 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of TNFR1 expression
|
|
US6013522A
(en)
|
1999-02-23 |
2000-01-11 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of human Smad1 expression
|
|
US6025198A
(en)
|
1999-06-25 |
2000-02-15 |
Isis Pharmaceuticals Inc. |
Antisense modulation of Ship-2 expression
|
|
US6033910A
(en)
|
1999-07-19 |
2000-03-07 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of MAP kinase kinase 6 expression
|
|
FR2801218B1
(fr)
|
1999-11-23 |
2001-12-28 |
Hoechst Marion Roussel Inc |
Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
|
|
US7754709B2
(en)
|
2003-06-10 |
2010-07-13 |
Solvay Pharmaceuticals Bv |
Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
|
|
US20090169585A1
(en)
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US20050158376A1
(en)
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
WO2005108415A2
(en)
|
2004-04-30 |
2005-11-17 |
Biogen Idec Ma Inc. |
Membrane associated molecules
|
|
JP5236286B2
(ja)
|
2004-05-07 |
2013-07-17 |
セレラ コーポレーション |
肝線維症に関連する遺伝的多型、その検出方法および使用
|
|
FR2904000A1
(fr)
|
2006-07-19 |
2008-01-25 |
Galderma Res & Dev S N C Snc |
Modulateurs de hsd17b7 dans le traitement de l'acne ou de l'hyperseborrhee
|
|
US20080300170A1
(en)
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
|
US20090203602A1
(en)
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
WO2008091873A2
(en)
|
2007-01-24 |
2008-07-31 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours
|
|
JP2010540444A
(ja)
|
2007-09-20 |
2010-12-24 |
レスベラトロル パートナーズ， エルエルシー |
遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物
|
|
US20110130442A1
(en)
|
2008-06-04 |
2011-06-02 |
Kyowa Hakko Kirin Co., Ltd. |
Nucleic acid capable of controlling degranulation of mast cell
|
|
US20100056384A1
(en)
*
|
2008-09-04 |
2010-03-04 |
Board Of Regents, The University Of Texas System |
Sequence Variations in PNPLA3 Associated with Hepatic Steatosis
|
|
US20100209427A1
(en)
|
2008-09-24 |
2010-08-19 |
Yu Li |
Lysine acetylation sites
|
|
EP2177615A1
(en)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
|
|
JPWO2010064702A1
(ja)
|
2008-12-05 |
2012-05-10 |
国立大学法人 東京大学 |
癌の予後を予測するためのバイオマーカー
|
|
CA2697169A1
(en)
|
2009-03-18 |
2010-09-18 |
David Stojdl |
Compositions and methods for augmenting activity of oncolytic viruses
|
|
US20120028816A1
(en)
|
2009-03-31 |
2012-02-02 |
Warren Stephen T |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
|
CA2767972A1
(en)
|
2009-07-15 |
2011-01-20 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
WO2011006214A1
(en)
|
2009-07-16 |
2011-01-20 |
Peter Maccallum Cancer Institute |
Method of detecting radiation exposure and adverse toxicity thereto
|
|
BR112012012513A2
(pt)
|
2009-11-25 |
2017-01-10 |
Prometheus Lab Inc |
método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo
|
|
WO2011084747A2
(en)
|
2009-12-21 |
2011-07-14 |
The Johns Hopkins University |
Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
|
|
WO2011127561A1
(en)
|
2010-04-12 |
2011-10-20 |
University Health Network |
Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
|
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
CA2799165C
(en)
|
2010-05-12 |
2022-04-12 |
Steven E. Schutzer |
Diagnostic markers for neuropsychiatric disease
|
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
|
US20120058088A1
(en)
|
2010-06-28 |
2012-03-08 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Methods Of Use
|
|
CA2804763C
(en)
|
2010-07-14 |
2023-01-03 |
The Regents Of The University Of California |
Biomarkers for diagnosis of transient ischemic attacks
|
|
WO2012031008A2
(en)
|
2010-08-31 |
2012-03-08 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
|
WO2012052953A1
(en)
|
2010-10-20 |
2012-04-26 |
Fondazione Centro San Raffaele Del Monte Tabor |
MiRNA
|
|
US9617514B2
(en)
|
2010-10-26 |
2017-04-11 |
Buck Institute For Research On Aging |
Downregulation of SINE/ALU retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
CA2817256A1
(en)
|
2010-11-12 |
2012-05-18 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
WO2012070014A2
(en)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
|
|
EP2652149A2
(en)
|
2010-12-16 |
2013-10-23 |
Norwegian University of Science and Technology (NTNU) |
Single nucleotide polymorphism associated with risk of insulin resistance development
|
|
DK2655621T3
(en)
|
2010-12-20 |
2018-08-13 |
Massachusetts Gen Hospital |
Polycomb-associated non-coding RNAS
|
|
WO2012151346A1
(en)
|
2011-05-03 |
2012-11-08 |
Dermachip Inc. |
Expression signatures of genes and gene networks associated with skin aging
|
|
GB201112246D0
(en)
|
2011-07-15 |
2011-08-31 |
Univ Birmingham |
Diagnosis of alzheimer's disease
|
|
US20130079241A1
(en)
|
2011-09-15 |
2013-03-28 |
Jianhua Luo |
Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
|
|
WO2013126565A1
(en)
|
2012-02-24 |
2013-08-29 |
Lunyak Victoria V |
Downregulation of sine/alu retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
WO2013166264A2
(en)
|
2012-05-02 |
2013-11-07 |
University Of Georgia Research Foundation, Inc. |
Methods for altering virus replication
|
|
US9677138B2
(en)
|
2012-05-20 |
2017-06-13 |
Trustees Of Boston University |
Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
|
|
RS59199B1
(sr)
|
2012-05-25 |
2019-10-31 |
Univ California |
Metode i jedinjenja za rnk-upravljanu ciljanu dnk modifikaciju i za rnk- upravljanu modulaciju transkripta
|
|
US20150147761A1
(en)
|
2012-06-20 |
2015-05-28 |
Helmut E. Meyer |
Specific biomarkers for hepatocellular carcinoma (hcc)
|
|
US20140004153A1
(en)
|
2012-07-02 |
2014-01-02 |
Lancell, L.L.C. |
Use of somatic mutations in the extracellular domain of transmembrane proteins in a patient's tumor as immunogens for active humoral immunotherapy of cancer
|
|
WO2014028946A2
(en)
|
2012-08-17 |
2014-02-20 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
|
US9375433B2
(en)
|
2012-09-26 |
2016-06-28 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
|
EP2900270B1
(en)
|
2012-09-26 |
2019-03-06 |
Tangent Reprofiling Limited |
Combination of benzo(iso)oxazolepiperidines with conjugated linoleic acid
|
|
WO2014089313A1
(en)
|
2012-12-05 |
2014-06-12 |
Alnylam Pharmaceuticals |
PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
|
|
ES2968649T3
(es)
|
2012-12-07 |
2024-05-13 |
Translate Bio Inc |
Nanopartículas lipídicas para la administración de ARNm en los pulmones
|
|
WO2014159443A1
(en)
|
2013-03-14 |
2014-10-02 |
Genomedx Biosciences, Inc. |
Cancer biomarkers and classifiers and uses thereof
|
|
US20160184458A1
(en)
|
2013-03-14 |
2016-06-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
EP2971128B1
(en)
|
2013-03-15 |
2023-03-01 |
Veracyte, Inc. |
Biomarkers for diagnosis of lung diseases and methods of use thereof
|
|
US20140329704A1
(en)
|
2013-03-28 |
2014-11-06 |
President And Fellows Of Harvard College |
Markers for mature beta-cells and methods of using the same
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
US9574241B2
(en)
|
2013-06-03 |
2017-02-21 |
The Trustees Of Columbia University In The City Of New York |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T-cell lymphomas
|
|
EP3004376B1
(en)
|
2013-06-03 |
2018-05-09 |
Nestec S.A. |
Methods for diagnosing chronic valvular disease
|
|
BR112015031608A2
(pt)
|
2013-06-17 |
2017-08-22 |
Massachusetts Inst Technology |
Aplicação e uso dos sistemas crispr-cas, vetores e composições para direcionamento e terapia hepáticos
|
|
ES2767318T3
(es)
|
2013-06-17 |
2020-06-17 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para generar modelos y actuar sobre enfermedades y trastornos de células posmitóticas
|
|
EP3019186A4
(en)
|
2013-07-12 |
2017-03-29 |
Patrick J. Casey |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
US20150079062A1
(en)
|
2013-07-12 |
2015-03-19 |
Patrick J. Casey |
Method for harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
RU2545990C2
(ru)
|
2013-07-16 |
2015-04-10 |
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы |
Способ дифференциальной диагностики стеатоза печени и стеатогепатита
|
|
EP3871696B1
(en)
|
2013-10-22 |
2025-03-19 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger rna
|
|
CN103520724B
(zh)
*
|
2013-10-23 |
2016-05-25 |
江苏美迪森生物医药有限公司 |
Hsd17b13蛋白或其编码基因的抑制剂的新用途
|
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
|
EP3139923B1
(en)
|
2014-05-09 |
2023-09-27 |
Tangent Reprofiling Limited |
Composition for treating pancreatic adenocarcinoma
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
WO2016004387A1
(en)
|
2014-07-02 |
2016-01-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Gene expression signature for cancer prognosis
|
|
WO2016009246A1
(en)
|
2014-07-14 |
2016-01-21 |
Casey Patrick J |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
US20170247758A1
(en)
|
2014-08-18 |
2017-08-31 |
Drexel University |
Methods, computer-readable media, and systems for assessing samples and wounds, predicting whether a wound will heal, and monitoring effectiveness of a treatment
|
|
CN114606309A
(zh)
|
2014-11-05 |
2022-06-10 |
威拉赛特公司 |
使用机器学习和高维转录数据的诊断系统和方法
|
|
JP2018510621A
(ja)
|
2015-02-13 |
2018-04-19 |
アルナイラム ファーマシューティカルズ， インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
パタチン様ホスホリパーゼドメイン含有３（ＰＮＰＬＡ３）ｉＲＮＡ組成物およびその使用方法
|
|
CN104698108B
(zh)
|
2015-03-26 |
2016-11-09 |
中国药科大学 |
一种利用固定化酶筛选I型17β羟类固醇脱氢酶抑制剂的方法
|
|
EP3350328A1
(en)
|
2015-09-14 |
2018-07-25 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
|
|
EP3159407A1
(en)
|
2015-10-23 |
2017-04-26 |
Silence Therapeutics (London) Ltd |
Guide rnas, methods and uses
|
|
WO2017100542A1
(en)
|
2015-12-10 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof
|
|
CA3005090A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of liver diseases
|
|
CA3005249A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of kidney diseases
|
|
CA3005128A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of eye diseases
|
|
CA3005254A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of retinitis pigmentosa 18 and retinitis pigmentosa 13
|
|
CA3005245A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of alagille syndrome
|
|
CA3005131A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of tuberous sclerosis complex
|
|
WO2017106382A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of central nervous system diseases
|
|
WO2017156310A1
(en)
|
2016-03-09 |
2017-09-14 |
Molecular Stethoscope, Inc. |
Methods and systems for detecting tissue conditions
|
|
EP3429347A4
(en)
|
2016-03-16 |
2020-07-29 |
Spogen Biotech Inc. |
PROCESSES FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICRO-ORGANISMS OVEREXPRESSING ENZYMES
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
US10036024B2
(en)
|
2016-06-03 |
2018-07-31 |
Purdue Research Foundation |
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
|
|
GB201609977D0
(en)
|
2016-06-08 |
2016-07-20 |
Cancer Rec Tech Ltd |
Chemosensitivity predictive biomarkers
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
SG10202106058WA
(en)
|
2016-12-08 |
2021-07-29 |
Intellia Therapeutics Inc |
Modified guide rnas
|
|
EP3551169A4
(en)
|
2016-12-09 |
2020-09-09 |
Sangamo Therapeutics, Inc. |
TARGET-SPECIFIC NUCLEASES ADMINISTRATION
|
|
WO2018112282A1
(en)
|
2016-12-14 |
2018-06-21 |
Ligandal, Inc. |
Compositions and methods for nucleic acid and/or protein payload delivery
|
|
WO2018136702A1
(en)
*
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
CN111108207A
(zh)
|
2017-06-02 |
2020-05-05 |
国家健康与医学研究院 |
用于遗传障碍的基因疗法的基因组编辑手段和结合病毒载体的基因疗法
|
|
CN111183234A
(zh)
*
|
2017-10-11 |
2020-05-19 |
雷杰纳荣制药公司 |
在表达pnpla3 i148m变异的患者的肝病治疗中对hsd17b13的抑制
|
|
CA3093547A1
(en)
|
2018-03-21 |
2019-09-26 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
|
BR112020018758A2
(pt)
|
2018-03-21 |
2021-01-26 |
Regeneron Pharmaceuticals, Inc. |
agente de ácido ribonucleico de fita dupla, célula, vetor, composição farmacêutica, e, métodos para inibição da expressão de 17¿-hidroxiesteroide desidrogenases tipo 13, para tratamento de um indivíduo, para prevenção de um sintoma em um indivíduo, para redução do risco de desenvolver doença hepática crônica, para inibição da progressão de esteatose, para inibição do acúmulo de gotículas de lipídios
|
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
EP3802828A4
(en)
|
2018-06-08 |
2022-10-26 |
Intellia Therapeutics, Inc. |
RNA MODIFIED GUIDES FOR GENE EDITING
|
|
EP3810148A4
(en)
|
2018-06-19 |
2022-06-08 |
The Board Of Regents Of The University Of Texas System |
Lipid nanoparticle compositions for delivery of mrna and long nucleic acids
|
|
WO2021003295A1
(en)
|
2019-07-02 |
2021-01-07 |
Regeneron Pharmaceuticals, Inc. |
Modulators of hsd17b13 and methods of use thereof
|